BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector ... disease, chronic kidney disease (CKD), and chronic obstructive pulmonary disease (COPD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback